University of Cambridge Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Oxford Featured PhD Programmes
University of Southampton Featured PhD Programmes
Centre for Genomic Regulation (CRG) Featured PhD Programmes
"clinical" AND "neuroscie…×
10 miles

Pharmacology / Toxicology (clinical neuroscience) PhD Projects, Programs & Scholarships

We have 9 Pharmacology / Toxicology (clinical neuroscience) PhD Projects, Programs & Scholarships

  • "clinical" AND "neuroscience" ×
  • Pharmacology / Toxicology×
  • clear all
Order by 
Showing 1 to 9 of 9
  UCL-Birkbeck MRC Doctoral Training Programme across 4 strategic themes

Funding Type

PhD Type

The UCL-Birkbeck MRC Doctoral Training Programme provides state-of-the-art PhD training across four strategic themes. Fundamental mechanisms of disease.
  UCL-Birkbeck MRC Doctoral Training Programme across 4 strategic themes

Funding Type

PhD Type

The UCL-Birkbeck MRC Doctoral Training Programme provides state-of-the-art PhD training across four strategic themes. Fundamental mechanisms of disease.
  MASTERS BY RESEARCH PROJECT: Can we improve patient outcomes by providing a more personalized approach to antiplatelet therapies?
  Dr S Mundell
Applications accepted all year round

Funding Type

PhD Type

Start 23 September 2019. This MSc by Research is a laboratory-based project which offers the exciting opportunity to spend 1 year in one of our State-of-the-Art laboratories (plus 1 year thesis writing) at the University of Bristol and experience life as a researcher.
  A personalised medicine approach to the treatment of low dose interleukin-2 in amyotrophic lateral sclerosis: predicting patients’ response through blood transcriptomics
  Dr J Kirby, Dr D Wang
Application Deadline: 29 January 2020

Funding Type

PhD Type

Background. The Horizon 2020 funded project, MIROCALS, is a clinical trial of low-dose interleukin-2 (IL-2) in patients with amyotrophic lateral sclerosis (ALS), an adult onset neurodegenerative disorder.
  Investigating the in vivo targets and mechanism of action of a toxic acetylcholinesterase-derived peptide upregulated in Alzheimer’s disease.
  Dr M Collins
Application Deadline: 6 January 2020

Funding Type

PhD Type

Project description. Alzheimer’s disease (AD) is a progressive neurodegenerative disease that is characterised by the deposition and accumulation of amyloid beta plaques and phosphorylated tau filaments in the brain, the latter correlating with the onset of symptoms.
  MRC DiMeN Doctoral Training Partnership: Investigating the in vivo targets and mechanism of action of a toxic acetylcholinesterase-derived peptide upregulated in Alzheimer’s disease
  Dr M Collins, Prof S Greenfield
Application Deadline: 6 January 2020

Funding Type

PhD Type

Alzheimer’s disease (AD) is a progressive neurodegenerative disease that is characterised by the deposition and accumulation of amyloid beta plaques and phosphorylated tau filaments in the brain, the latter correlating with the onset of symptoms.
  4 year DPhil (PhD) in Cardiovascular Science

Funding Type

PhD Type

Cardiovascular disease, including heart attacks and strokes, remains the leading cause of premature death and disability in Europe and the USA.
  The role of the metabotropic glutamate receptor type 5 in motor neuron disease (MND)
  Dr R Mead, Dr L Ferraiuolo, Dr J Alix, Prof PJ Shaw
Application Deadline: 20 December 2019

Funding Type

PhD Type

A major focus of research within the internationally recognised Sheffield Institute for Translational Neuroscience (SITraN) is to understand the pathways leading to neurodegeneration, and to identify new approaches which will protect neurons.
  Reward Processing and Depression using Neuroimaging
  Prof C McCabe
Applications accepted all year round

Funding Type

PhD Type

In our research group we are interested in how the brains response to reward and aversion might be a biomarker for risk to depression in adults and adolescents.
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2019
All rights reserved.